Andrew  Hykes net worth and biography

Andrew Hykes Biography and Net Worth

CEO, President & Director of Inari Medical
Drew is a proven medical device operating executive with broad functional, geographic and sector experience. From 2012-2016 Drew served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market. Sequent was acquired by Terumo Corporation in July 2016 for $380 million. Prior to Sequent, Drew spent 11 years at Medtronic. His roles at Medtronic included the VP of Marketing for the AF Solutions business, VP of Clinical and Regulatory for the AF Solutions business and Director of Investor Relations. Drew also spent three years on an expatriate assignment in Europe leading the launch of Medtronic’s first drug eluting coronary stent. Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions. He earned a B.B.A. in Finance from the University of Wisconsin and an MBA from Harvard Business School.

What is Andrew Hykes' net worth?

The estimated net worth of Andrew Hykes is at least $22.96 million as of October 29th, 2024. Mr. Hykes owns 445,310 shares of Inari Medical stock worth more than $22,955,731 as of December 3rd. This net worth evaluation does not reflect any other investments that Mr. Hykes may own. Additionally, Mr. Hykes receives an annual salary of $1,540,000.00 as CEO, President & Director at Inari Medical. Learn More about Andrew Hykes' net worth.

How old is Andrew Hykes?

Mr. Hykes is currently 51 years old. There are 1 older executives and no younger executives at Inari Medical. Learn More on Andrew Hykes' age.

What is Andrew Hykes' salary?

As the CEO, President & Director of Inari Medical, Inc., Mr. Hykes earns $1,540,000.00 per year. Learn More on Andrew Hykes' salary.

How do I contact Andrew Hykes?

The corporate mailing address for Mr. Hykes and other Inari Medical executives is 9 Parker Suite 100, Irvine CA, 92618. Inari Medical can also be reached via phone at 877-923-4747 and via email at [email protected]. Learn More on Andrew Hykes' contact information.

Has Andrew Hykes been buying or selling shares of Inari Medical?

In the last ninety days, Andrew Hykes has sold $150,000.00 in Inari Medical stock. Most recently, Andrew Hykes sold 3,000 shares of the business's stock in a transaction on Tuesday, October 29th. The shares were sold at an average price of $50.00, for a transaction totalling $150,000.00. Following the completion of the sale, the chief executive officer now directly owns 445,310 shares of the company's stock, valued at $22,265,500. Learn More on Andrew Hykes' trading history.

Who are Inari Medical's active insiders?

Inari Medical's insider roster includes Rebecca Chambers (Director), Mitch Hill (CFO), William Hoffman (CEO), Andrew Hykes (CEO, President & Director), Donald Milder (Director), Kirk Nielsen (Director), and Thomas Tu (Insider). Learn More on Inari Medical's active insiders.

Are insiders buying or selling shares of Inari Medical?

In the last year, insiders at the sold shares 26 times. They sold a total of 531,244 shares worth more than $26,328,373.16. The most recent insider tranaction occured on November, 18th when Director William Hoffman sold 60,000 shares worth more than $3,069,600.00. Insiders at Inari Medical own 10.6% of the company. Learn More about insider trades at Inari Medical.

Information on this page was last updated on 11/18/2024.

Andrew Hykes Insider Trading History at Inari Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/29/2024Sell3,000$50.00$150,000.00445,310View SEC Filing Icon  
7/22/2024Sell3,000$55.23$165,690.00455,252View SEC Filing Icon  
7/1/2024Sell3,000$50.08$150,240.00462,474View SEC Filing Icon  
5/28/2024Sell3,000$50.00$150,000.00465,474View SEC Filing Icon  
11/16/2023Sell37,448$59.82$2,240,139.36434,817View SEC Filing Icon  
8/16/2023Sell36,676$66.11$2,424,650.36475,132View SEC Filing Icon  
5/16/2023Sell17,916$70.87$1,269,706.92532,368View SEC Filing Icon  
3/20/2023Sell9,000$64.29$578,610.00552,283View SEC Filing Icon  
1/20/2023Sell9,000$61.90$557,100.0093,046View SEC Filing Icon  
12/20/2022Sell9,000$68.50$616,500.00102,998View SEC Filing Icon  
11/21/2022Sell9,000$77.66$698,940.00111,998View SEC Filing Icon  
10/20/2022Sell9,000$72.33$650,970.00120,998View SEC Filing Icon  
9/6/2022Sell5,000$70.00$350,000.00130,991View SEC Filing Icon  
8/1/2022Sell5,000$78.67$393,350.00135,991View SEC Filing Icon  
7/5/2022Sell5,000$70.31$351,550.00140,991View SEC Filing Icon  
6/7/2022Sell5,000$70.08$350,400.00146,984View SEC Filing Icon  
2/28/2022Sell6,304$90.05$567,675.20View SEC Filing Icon  
1/18/2022Sell5,000$76.65$383,250.00View SEC Filing Icon  
10/19/2021Sell9,000$87.76$789,840.00View SEC Filing Icon  
9/17/2021Sell9,000$80.75$726,750.00170,975View SEC Filing Icon  
8/19/2021Sell9,000$72.66$653,940.00View SEC Filing Icon  
7/19/2021Sell9,000$85.21$766,890.00View SEC Filing Icon  
6/21/2021Sell1,001$91.41$91,501.41204,711View SEC Filing Icon  
6/18/2021Sell7,999$92.29$738,227.71204,711View SEC Filing Icon  
5/19/2021Sell9,000$82.77$744,930.00203,111View SEC Filing Icon  
4/19/2021Sell9,000$103.18$928,620.00212,297View SEC Filing Icon  
3/19/2021Sell9,000$109.24$983,160.00221,571View SEC Filing Icon  
2/19/2021Sell9,000$117.74$1,059,660.00211,971View SEC Filing Icon  
1/19/2021Sell9,000$96.68$870,120.00204,641View SEC Filing Icon  
1/13/2021Sell27,600$95.04$2,623,104.00224,496View SEC Filing Icon  
1/5/2021Sell27,600$79.63$2,197,788.00253,655View SEC Filing Icon  
12/18/2020Sell27,400$70.85$1,941,290.00283,372View SEC Filing Icon  
11/30/2020Sell27,400$67.72$1,855,528.00313,541View SEC Filing Icon  
5/27/2020Buy5,650$19.00$107,350.00
See Full Table

Andrew Hykes Buying and Selling Activity at Inari Medical

This chart shows Andrew Hykes's buying and selling at Inari Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Inari Medical Company Overview

Inari Medical logo
Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $51.55
Low: $50.40
High: $52.00

50 Day Range

MA: $46.67
Low: $40.62
High: $53.35

2 Week Range

Now: $51.55
Low: $36.73
High: $67.13

Volume

494,939 shs

Average Volume

977,895 shs

Market Capitalization

$3.02 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.97